Sean Scanlan's Disposal of Treace Medical Concepts Common Stock

Sean Scanlan, the Chief Innovation Officer of Treace Medical Concepts, Inc., disposed of 208 shares of common stock on October 24, 2025. The transaction was reported under Form 4, with a transaction code 'F' indicating a disposition. The price per share was $0, and following the transaction, Scanlan owns 373,599 shares, which includes 283,948 restricted stock units. The filing was signed by Lisa Taylor as Attorney-in-fact for Sean Scanlan on October 28, 2025.